Association of early electrical changes with cardiovascular outcomes in immune checkpoint inhibitor myocarditis
John R. Power(UC San Diego Health System), Ellen Warner, Manhal Habib, Tyler Mehegan, Arjun K. Ghosh(University College Hospital), Ryota Morimoto, Lorenz Lehmann(German Cancer Research Center), Benay Özbay(University of Pittsburgh Medical Center), Osnat Itzhaki Ben Zadok, Javid J. Moslehi(Cardiovascular Institute of the South), Shi Huang(Vanderbilt University Medical Center), Yves Allenbach(Sorbonne Université), Kambiz Ghafourian, Grace K. Dy(Roswell Park Comprehensive Cancer Center), Anita Deswal(The University of Texas MD Anderson Cancer Center), Nicolas L. Palaskas(The University of Texas MD Anderson Cancer Center), Marie-Claire Zimmer, Wei‐Ting Chang(National Sun Yat-sen University), Lauren Gilstrap(Dartmouth College), Lawrence D. Piro, Dimitri Arangalage, Danette Flint, Cecilia Monge(National Cancer Institute), Ben Stringer, Sergey V. Brodsky(The Ohio State University), Avirup Guha(The Ohio State University), Stéphane Éderhy, Martin Nicol, Shanthini Mary Crusz(Barts Health NHS Trust), Jennifer Cautela(Hôpital Nord), V. Gounant, Elvire Mervoyer, Amy L. Copeland, Charlotte Fenioux(Assistance Publique – Hôpitaux de Paris), Darryl P. Leong(Population Health Research Institute), Baptiste Abbar(Inserm), Salim S. Hayek(Rush University Medical Center), Joe‐Elie Salem(Inserm), Franck Thuny(Assistance Publique Hôpitaux de Marseille), Johnny Chahine, Aarti Asnani(Beth Israel Deaconess Medical Center), Yuichi Tamura(Kanazawa Hospital), Steven M. Ewer(UW Health University Hospital), Barouyr Baroudjian(Hôpital Saint-Louis), Nicolas Piriou(Centre Hospitalier Universitaire de Besançon), Joachim Alexandre(Government of the United States of America), Arrush Choudhary(Beth Israel Deaconess Medical Center), Daniel Finke(Heidelberg University), Mandar A. Aras(University of California San Francisco Medical Center), Tyler B. Moran(University of Illinois Urbana-Champaign)
Cited by 38
Related Papers
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal|2022|2.7k
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
|New England Journal of Medicine|2016|2.3k
Sotorasib for Lung Cancers with <i>KRAS</i> p.G12C Mutation
|New England Journal of Medicine|2021|1.8k
2023 ESC Guidelines for the management of endocarditis
|European Heart Journal|2023|1.6k